Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practice

V.P. Bykerk, A.J.K. Ostor, J. Alvaro-Gracia, K. Pavelka, J.A.R. Ivorra, W. Graninger, W. Bensen, M.T. Nurmohamed, A. Krause, C. Bernasconi, A. Stancati, J Sibilia

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1950-1954
JournalAnnals of the Rheumatic Diseases
Issue number12
Publication statusPublished - 2012

Cite this